We serve Chemical Name:3-phenyl-1-pyridin-2-yl-5,6,7,8,9,10,11,12,13,14-decahydrocyclododeca[c]pyridine CAS:871798-86-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![3-phenyl-1-pyridin-2-yl-5,6,7,8,9,10,11,12,13,14-decahydrocyclododeca[c]pyridine](https://a.dearchem.com/CAS2/871798-86-6.png)
Chemical Name:3-phenyl-1-pyridin-2-yl-5,6,7,8,9,10,11,12,13,14-decahydrocyclododeca[c]pyridine
CAS.NO:871798-86-6
Synonyms:3-Phenyl-1-(pyridin-2-yl)-5,6,7,8,9,10,11,12,13,14-decahydrocyclododeca[c]pyridine;Cyclododeca[c]pyridine,5,6,7,8,9,10,11,12,13,14-decahydro-3-phenyl-1-(2-pyridinyl)
Molecular Formula:C26H30N2
Molecular Weight:370.53000
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:533.79ºC at 760 mmHg
Density:1.03g/cm3
Index of Refraction:1.559
PSA:25.78000
Exact Mass:370.24100
LogP:7.03000
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Phenyl-1-(pyridin-2-yl)-5,6,7,8,9,10,11,12,13,14-decahydrocyclododeca[c]pyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Cyclododeca[c]pyridine,5,6,7,8,9,10,11,12,13,14-decahydro-3-phenyl-1-(2-pyridinyl) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Phenyl-1-(pyridin-2-yl)-5,6,7,8,9,10,11,12,13,14-decahydrocyclododeca[c]pyridine Use and application,Cyclododeca[c]pyridine,5,6,7,8,9,10,11,12,13,14-decahydro-3-phenyl-1-(2-pyridinyl) technical grade,usp/ep/jp grade.
Related News: In Massachusetts, where the bulk of Takeda’s U.S. operations are based since the Shire buyout, the Japanese pharma has been swiftly ramping up its cell therapy ambitions. In September, the company cut the ribbon on a new 24,000-square-foot R&D manufacturing center in Boston, which it said at the time would handle clinical development for three ongoing pipeline programs and two other prospects pegged to enter clinical development by the end of 2021. 4-methylumbelliferyl-beta-d-lactoside manufacturers Standard therapy consisted of oral corticosteroids (OCS), antimalarials and immunosuppressants (methotrexate, azathioprine or mycophenolate mofetil, known as MMF). 3-Cyanoumbelliferone suppliers “In the past few years, the pharmaceutical industry has seen rapid growth driven by the growth of small molecules’ innovations, complex APIs and the increasing need to optimize available resources. 4-Amino-2,5-dimethylphenol vendor & factory.
